IIM Udaipur Hosts ‘Startup Showcase & Pitch Day’ Organized by IIM Udaipur Incubation Centre and Saksham – The Entrepreneurship Cell
UDAIPUR, India, Nov. 12, 2025 /PRNewswire/ -- The Indian Institute of Management Udaipur…
Cell Impact has been awarded gold medal by EcoVadis
KARLSKOGA, Sweden, Nov. 11, 2025 /PRNewswire/ -- Last year, Cell Impact was…
Ernexa Therapeutics to Present at Oxford Globals Cell 2025
Sanjeev Luther, President and CEO to give an oral presentation and participate…
Cell Impact and thyssenkrupp Automation Engineering have entered a cooperation agreement
KARLSKOGA, Sweden, Nov. 6, 2025 /PRNewswire/ -- Cell Impact and thyssenkrupp Automation Engineering have…
Fulcrum Therapeutics to Present New Clinical Data from the PIONEER trial of Pociredir in Sickle Cell Disease at the 67th American Society of Hematology Annual Meeting
November 03, 2025 16:45 ET | Source: Fulcrum Therapeutics, Inc. ― Pociredir…
Cullinan Therapeutics Shares Additional Preclinical B Cell Depletion Data for CLN-978, Supporting Clinical Development Across Multiple Autoimmune Diseases, at ACR Convergence 2025
October 25, 2025 11:01 ET | Source: Cullinan Therapeutics, Inc. CLN-978 led…
Galapagos Announces Intention to Wind Down Cell Therapy Business as Part of the Companys Ongoing Transformation
Intention follows comprehensive strategic review process and would represent the optimal capital…
Precede Biosciences Presents New ESMO 2025 Data Demonstrating Its Liquid Biopsy Platforms Ability to Resolve Target Expression and Molecular Subtypes in Small Cell Lung Cancer
Small cell lung cancer (SCLC) accounts for 15% of all lung cancers…
Ariceum Therapeutics Data at the 2025 European Association of Nuclear Medicine Annual Congress Further Supports the Advancement of 225Ac-SSO110 for Extensive Stage Small Cell Lung Cancer and Merkel Cell Carcinoma
October 09, 2025 02:00 ET | Source: Ariceum Therapeutics Oral presentation by…
FDA approves Roches Tecentriq plus lurbinectedin as first-line maintenance therapy for extensive-stage small cell lung cancer
Combination reduced the risk of disease progression or death by 46% and…
